Clinical Decision Support Systems Market To Reach $10.71 Billion By 2030

Clinical Decision Support Systems Market Growth & Trends

The global clinical decision support systems market size is anticipated to reach USD 10.71 billion in 2030 and is projected to grow at a CAGR of 11.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.

During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.

Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.

Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.

 Request a free sample copy or view report summary: Clinical Decision Support Systems Market Report

Clinical Decision Support Systems Market Report Highlights

• Researchers are integrating AI into Clinical Decision Support Systems (CDSS) to process vast data to recommend treatment strategies, highlight potential issues, streamline operations, and support healthcare professionals.

• Standalone CDSS held the largest market share of 30.7% in 2024, because it is widely adopted for its low cost and simplicity. They don't require standardization or extensive clinical expertise and can operate without real patient data.

• Drug allergy alerts accounted for the largest market share of 25.7% in 2024. Several people have allergies to specific drugs, so it is important to have systems that provide allergy alerts

• CDSS services held the largest market share of 42.3% in 2024, as it offers implementation, training, support, customization, and consulting services to help healthcare organizations maximize the value of CDSS software and optimize clinical decision-making

• On-premise segment in delivery mode dominated the market with the largest share of 41.9% in 2024. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs.

• The Clinical Decision Support Systems market in North America accounted for a share of 25.3% of the global revenue in 2024. North American consumers tend to prioritize Clinical Decision Support Systems that reflects current trends, personal style, and individual expression

• North America clinical decision support systems market dominated the global market with over 43.10% revenue share in 2024. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services

Clinical Decision Support Systems Market Segmentation

Grand View Research has segmented the global clinical decision support systems market report based on product, application, delivery mode, component, and region:

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standalone CDSS

• Integrated CPOE with CDSS

• Integrated EHR with CDSS

• Integrated CDSS with CPOE & EHR

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug-drug interactions

• Drug allergy alerts

• Clinical reminders

• Clinical guidelines

• Drug dosing support

• Others

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Web-based Systems

• Cloud-based Systems

• On -premise Systems

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware

• Software

• Services

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • Italy

  • Spain

  • France

  • Sweden

  • Denmark

  • Norway

  • RoE

• Asia Pacific

  • China

  • India

  • Japan

  • Thailand

  • South Korea

  • Australia

  • RoAPAC

• Latin America

  • Brazil

  • Argentina

  • RoLATM

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • RoMEA

List of Key Players in Clinical Decision Support Systems Market

• McKesson Corporation

• Cerner Corporation

• Siemens Healthineers GmbH

• Allscripts Healthcare, LLC

• athenahealth, Inc.

• NextGen Healthcare Inc.

• Koninklijke Philips N.V. (Royal Philips)

• IBM Corporation

• Agfa-Gevaert Group

• Wolters Kluwer N.V.

• Becton, Dickinson and Company

• Cabot Technology Solutions

• GE HealthCare

• Nordic

• BeeKeeperAI

• BSCO Industries, Inc.